Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

X-COR Therapeutics provides a less invasive way to remove excess CO2 from patients with acute respiratory failure, enabling safer and more accessible respiratory support. The company offers a…

X-COR Therapeutics provides a less invasive way to remove excess CO2 from patients with acute respiratory failure, enabling safer and more accessible respiratory support. The company offers a…
What they do: Develop an ultra-low-blood-flow extracorporeal CO2 removal medical device for acute respiratory failure
Founded: 2017
Tech / approach: Patent-pending hybrid consumable cartridge + machine-learning control algorithm; <300 ml/min blood flows
Target setting: Hospital and critical-care settings; aim to enable use outside ICU with smaller catheters and simpler workflows
Recent funding signal: Seed round Nov 12, 2020; investors include Alira Health Ventures and others
Acute hypercarbic respiratory failure; extracorporeal CO2 removal to reduce need for high-flow respiratory therapies
2017
Biotechnology
Latest disclosed round per company profiles (multiple seed rounds listed across history)
“Has raised multiple seed rounds and lists investors including Alira Health Ventures, Flybridge, Good Growth Capital, MassChallenge, MedTech Innovator, PiSA Biopharm, and The Graduate Syndicate”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
58,000+
Open Roles
2,700+
New This Week